In vivo Approach: Potential Diuretic Activity of M. charantia Linn. on Alloxan Induced Albino Wistar Rats in Diabetes Mellitus

Main Article Content

Umesh B. Wahul
Ambadas S. Kadam
Laxmikant H. Kamble
Ayaz S. Ali

Abstract

The screening of perfect diuretics for non –clinical utility in Diabetes mellitus is a relatively novel approach which gain insight into underlying the pathophysiological processes.

This study aim to evaluate the diuretic effect of crude aqueous & alcoholic extract of M. charantia Linn. using Albino Wistar Rat model. The methodology of animal study includes the spectral analysis of Na+, K+, Cl-concentration against the body weight, this was done by spectrophotometry. In this study, the comparative observation of Diuretic activity with standard and extracted compound has shown that the estimated 24‐hour urine contains the Na+-3.82 g, 3.82 g, 3.92 g  and K+-1.35 g, 1.39 g, 1.48 gwt. For Vehicle control, Standard drug, and Extracted compound respectively. Which possess the favouring result means from the spot urine were 10.7±7.0 g/24 hand 3.9±2.1 g/24 h, respectively. Coefficients were 0.035, 0.022, 0.046 at (d±2SD=7.07 g, 4.42 gand 8.92 g) for sodium chloride and 0.068, 0.031, 0.046 at (d ± 2SD = 4.92 g, 2.31 g and 3.34 g) for potassium chloride. The present study guide formulation of non-clinical trials with statistical study to further measuring the claimed efficacy of M. charantia as a natural remedy for diabetes mellitus.

Keywords:
M. charantia Linn. furosemide, normalsaline, ANOVA, p-valuesetc

Article Details

How to Cite
Wahul, U. B., Kadam, A. S., Kamble, L. H., & Ali, A. S. (2020). In vivo Approach: Potential Diuretic Activity of M. charantia Linn. on Alloxan Induced Albino Wistar Rats in Diabetes Mellitus. European Journal of Medicinal Plants, 31(8), 61-75. https://doi.org/10.9734/ejmp/2020/v31i830259
Section
Original Research Article

References

Baynes JW. Role of oxidative stress in development of complications in diabetes, Diabetes. 1991;40(4):405-412.

Bambolkar S, Sainani GS. Evaluation of oxidative stress in diabetics with or without vascular complications. J. Asso. Phys. India. 2013;43:10-12.

Wohaieb SA, Godin DV. Alteration in free radical tissue defense mechanism in streptozotocin-induced diabetes in rat. Diabetes R. 1987;36(9):1014-8

Asayama K, Kayashibe H, Dobashi K, Niitsu T, Miyao A, Kato K, et.al. Antioxidant enzyme status and lipid peroxidation in various tissues of diabetic and starved rats. Diabetes Res.01. 1989;12(2):85- 91.

Aslam M, Jafri MA, Kalim Javed, Surendra Singh. Plant drug with hypoglycemic activity Glimpses in plant Research, Today and Tomorrow’s Printers and Publishers, New Delhi – 110005 (India).1998;(XII): 271-299.

Wahul U, Kadam A, Kamble L. A bio-herbal Medicinal Remedies: M charantia Linn. A Scope of Characterization of Medicinally Evaluating Antidiabetic Compound. Int J Pharma Bio Sci. 2018; 9(2):116-126.

Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): A mini review. Br J Nutr. 2009;102(12):1703-8.

Minghan Wang, Chapter 10, Current antidiabetic therapies and mechanisms; 2011.
Available:https://doi.org/10.1002/9780470910016.ch10

He F. Laemmli-SDS-PAGE. Bio-protocol Bio. 2011;101:e80.
DOI: 10.21769/BioProtoc.80

He F. Bradford Protein Assay. Bio-protocol Bio. 2011;101:e45.
DOI: 10.21769/BioProtoc.45

Government of India, Ministry of Environment, Forest & Climate Change; Compendium of CPCSEA. 2018, Available:www.cpcsea.nic.in

Taylor L. Herbal secrets of the rainforest. In: Texas A, editor. Bitter melon (Momordica charantia) 2nd ed. USA: Sage Press. 2002;63:1–100.

Jaipaul Singh, Emmanuel Cumming. medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions, Open Med Chem J. 2011;5:70–77.
Published online 2011

S. Kuma, B.S. Bajwa, Singh Kuldeep, A.N. Kalia; Anti-inflammatory Activity of Herbal Plants: A Review; IJAPBS. 2013;2(2):272-281.

Jimmy T, Efird, Yuk Ming Choi, Stephen W. Davies, Sanjay Mehra, Ethan J. Anderson Lalage A. Katunga, et al; Potential for improved glycemic control with dietary Momordica charantia in Patients with insulin resistance and Pre-diabetes, Int. J. Environ. Res. Public Health. 2014;11:2328-2345.